Cargando…
Changing TACTICS in intermediate HCC: TACE plus sorafenib
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398463/ https://www.ncbi.nlm.nih.gov/pubmed/32169908 http://dx.doi.org/10.1136/gutjnl-2020-320692 |
| _version_ | 1783565964588089344 |
|---|---|
| author | Radu, Pompilia Dufour, Jean-François |
| author_facet | Radu, Pompilia Dufour, Jean-François |
| author_sort | Radu, Pompilia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7398463 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73984632020-08-17 Changing TACTICS in intermediate HCC: TACE plus sorafenib Radu, Pompilia Dufour, Jean-François Gut Commentary BMJ Publishing Group 2020-08 2020-03-13 /pmc/articles/PMC7398463/ /pubmed/32169908 http://dx.doi.org/10.1136/gutjnl-2020-320692 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
| spellingShingle | Commentary Radu, Pompilia Dufour, Jean-François Changing TACTICS in intermediate HCC: TACE plus sorafenib |
| title | Changing TACTICS in intermediate HCC: TACE plus sorafenib |
| title_full | Changing TACTICS in intermediate HCC: TACE plus sorafenib |
| title_fullStr | Changing TACTICS in intermediate HCC: TACE plus sorafenib |
| title_full_unstemmed | Changing TACTICS in intermediate HCC: TACE plus sorafenib |
| title_short | Changing TACTICS in intermediate HCC: TACE plus sorafenib |
| title_sort | changing tactics in intermediate hcc: tace plus sorafenib |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398463/ https://www.ncbi.nlm.nih.gov/pubmed/32169908 http://dx.doi.org/10.1136/gutjnl-2020-320692 |
| work_keys_str_mv | AT radupompilia changingtacticsinintermediatehcctaceplussorafenib AT dufourjeanfrancois changingtacticsinintermediatehcctaceplussorafenib |